Minimizing immunotherapy’s potentially harmful side effects

by

Recent advances in treating multiple myeloma, the second most common blood cancer, and other blood malignancies are providing improved outcomes—and hope—to patients worldwide.

Leave A Comment

Your email address will not be published. Required fields are marked *